Showing results (141-150 of 154) with videos related to
Sort By:
Pageof 16
Acta Oto-Laryngologica|December 12, 2013
Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expressionChi Zhang, Xi Yang, Qu Zhang, et al.Journal of Hematology & Oncology|August 21, 2014
Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repairQin Qin, Hongyan Cheng, Jing Lu, et al.The Journal of Biological Chemistry|July 27, 2019
The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1Suiyi Tan, Jin-Qing Li, Hongyan Cheng, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 2, 2014
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1αChi Zhang, Xi Yang, Qu Zhang, et al.Scientific Reports|September 29, 2015
Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxiaHongcheng Zhu, Xi Yang, Yuqiong Ding, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2026
Real-Time in Vivo Monitoring of Circulating Endometrial Cells: Uncovering Systemic Dissemination and Temporal Fluctuations in EndometriosisShang Wang, Chenyu Hou, Buyun Li, et al.Tumori|March 21, 2015
Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinomaXiaolin Ge, Xi Yang, Xiaohu Lu, et al.Frontiers in Immunology|August 19, 2021
Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian CancerHongyan Cheng, Ruiqiong Ma, Shang Wang, et al.International Journal of Nanomedicine|May 8, 2009
Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsBaoan Chen, Jian Cheng, Mingfang Shen, et al.Eclinicalmedicine|May 8, 2023
Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective studyXiaoyu Wang, Wei Cang, Xiaomei Liu, et al.Pageof 16